Keywords: mgi/supergen, dacogen, filed, usa, new, drug, application

MGI/SuperGen's Dacogen filed in USA

Article | 08 November 2004

Print This

A New Drug Application seeking approval of MGI Pharma/SuperGen's Dacogen (decitabine) as a treatment for myelodysplastic syndromes has been ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in